Ovation Science Inc.
OVAT
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -59.33% | 5.50% | 221.21% | 1,960.00% | -0.33% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -59.33% | 5.50% | 221.21% | 1,960.00% | -0.33% |
| Cost of Revenue | -98.01% | -80.17% | 100.00% | -27.27% | -- |
| Gross Profit | -20.13% | 1,414.29% | 273.91% | 7,425.00% | -50.50% |
| SG&A Expenses | -28.15% | -57.59% | -21.79% | -27.46% | -16.92% |
| Depreciation & Amortization | -- | -100.00% | -33.33% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -39.13% | -52.11% | -24.55% | -33.51% | -6.10% |
| Operating Income | 33.78% | 56.64% | 31.39% | 49.36% | 7.60% |
| Income Before Tax | 35.15% | 87.89% | 9.31% | 71.60% | -6.44% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 35.15% | 87.89% | 9.31% | 71.60% | -6.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 35.15% | 87.89% | 9.31% | 71.60% | -6.44% |
| EBIT | 33.78% | 56.64% | 31.39% | 49.36% | 7.60% |
| EBITDA | 33.78% | 56.74% | 31.38% | 49.52% | 7.64% |
| EPS Basic | 36.84% | 89.36% | 24.49% | 71.21% | 9.52% |
| Normalized Basic EPS | 37.50% | 90.32% | 25.81% | 71.43% | 7.69% |
| EPS Diluted | 36.84% | 89.36% | 24.49% | 71.21% | 9.52% |
| Normalized Diluted EPS | 37.50% | 90.32% | 25.81% | 71.43% | 7.69% |
| Average Basic Shares Outstanding | 2.31% | 6.29% | 19.98% | 0.00% | 16.40% |
| Average Diluted Shares Outstanding | 2.31% | 6.29% | 19.98% | 0.00% | 16.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |